Engineering long-lasting joint lubrication by mimicking nature

20 Aug 2014

1

By finding a way to bind a slippery molecule naturally found in the fluid that surrounds healthy joints, Johns Hopkins researchers have engineered surfaces that have the potential to deliver long-lasting lubrication at specific spots throughout the body.

The finding, described in the 3 August online edition of Nature Materials, could eventually offer a new way to ease the pain of arthritic joints, keep artificial joints working smoothly or even make contact lenses more comfortable.

According to the investigators, scientists have long known that a biochemical known as hyaluronic acid (HA), found in abundance in joints' synovial fluid, is an important component for naturally lubricating tissues.

One form of HA also reduces inflammation and protects cells from metabolic damage.

Diseased, damaged or ageing joints in hips, knees, shoulders and elbows often have far lower concentrations of HA, presumably because a protein that binds HA molecules to joint surfaces is no longer able to retain HA where it is needed.

HA injections into painful joints, known as viscosupplementation, have become a popular way to treat painful joints in the past several years. But without a way to retain HA at the site, the body's natural cleaning processes soon wash it away.

Seeking a way to tackle this problem, a team led by Jennifer H. Elisseeff, Ph.D., professor at the Wilmer Eye Institute at Johns Hopkins and in the Johns Hopkins University departments of Biomedical Engineering and of Materials Science and Engineering, looked to molecules known as HA-binding peptides (HABpeps) that stick to HA.

In the laboratory, using HABpep as a chemical handle, the researchers used a second synthetic molecule, polyethylene glycol, to tie HA onto surfaces that included natural and artificial cartilage.

Tests on tissues and in animals show that the bound HA didn't easily wash away, and it reduced friction as successfully as when these tissues were immersed in a bath of HA.

When the researchers injected a HABpep designed to attach to cartilage in rat knees, then injected HA, that HA stuck around 12 times as long as it did in rats that hadn't been given HABpep, suggesting that these peptides could be a promising addition to viscosupplementation.

Though this material still has some time before it might be available to patients, Elisseeff notes its promise as another example of scientists looking to nature as an inspiration to solve medical problems.

''What I like about this concept is that we're mimicking natural functions that are lost using synthetic materials,'' Elisseeff says.

Other Johns Hopkins researchers who participated in this study include Anirudha Singh, Michael Corvelli, Shimon A. Unterman, Kevin A. Wepasnick and Peter McDonnel.

Latest articles

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Indians can now travel to 56 destinations without prior visa as passport ranking improves

Indians can now travel to 56 destinations without prior visa as passport ranking improves

CEO says EU’s IRIS2 must match Starlink on price and performance

CEO says EU’s IRIS2 must match Starlink on price and performance

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Opening the silos: India approves 3 million tonnes of wheat and product exports

Opening the silos: India approves 3 million tonnes of wheat and product exports

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round